The Janus kinase 1 is critical for pancreatic cancer initiation and progression.

Autor: Shrestha H; Department of Oncology, Wayne State University School of Medicine and Tumor Biology Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA., Rädler PD; Department of Oncology, Wayne State University School of Medicine and Tumor Biology Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA., Dennaoui R; Department of Oncology, Wayne State University School of Medicine and Tumor Biology Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA., Wicker MN; Department of Oncology, Wayne State University School of Medicine and Tumor Biology Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA., Rajbhandari N; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA., Sun Y; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Peck AR; Department of Pharmacology, Physiology & Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA., Vistisen K; Department of Oncology, Wayne State University School of Medicine and Tumor Biology Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA., Triplett AA; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA., Beydoun R; Department of Oncology, Wayne State University School of Medicine and Tumor Biology Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA; Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA., Sterneck E; Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA., Saur D; Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany; Translational Cancer Research and Institute of Experimental Cancer Therapy, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Rui H; Department of Pharmacology, Physiology & Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA., Wagner KU; Department of Oncology, Wayne State University School of Medicine and Tumor Biology Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA. Electronic address: kuwagner@wayne.edu.

Publikováno v: Cell reports [Cell Rep] 2024 May 28; Vol. 43 (5), pp. 114202. Date of Electronic Publication: 2024 May 10.

Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses.

Autor: Viola NT; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States., Glassbrook JE; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States.; Department of Biochemistry Microbiology and Immunology, Wayne State University, Detroit, MI, United States., Kalluri JR; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States., Hackett JB; Cancer Biology Graduate Program, School of Medicine, Wayne State University, Detroit, MI, United States., Wicker MN; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States., Sternberg J; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States., Gibson HM; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 May 11; Vol. 13, pp. 870110. Date of Electronic Publication: 2022 May 11 (Print Publication: 2022).